See how iDose can be used to forecast the transition from IV induction to subcutaneous vedolizumab in a patient with moderate Crohn’s disease. The walkthrough models the concentration-time profile across several subcutaneous doses, illustrating how concentrations may take multiple doses to reach and stabilize around the selected target trough. It also reviews predicted clearance and probability curves to provide additional context for the dosing forecast.